Philips, SyntheticMR partner on AI-based brain imaging

Philips has launched its Smart Quant Neuro 3D, a cutting-edge diagnostic and therapeutic system for brain disorders, in collaboration with SyntheticMR, a Swedish MRI software solutions company. Unveiled at ECR2024, this innovative platform offers objective decision support for conditions such as multiple sclerosis (MS), traumatic brain injury (TBI), and dementia. By automating the measurement of various brain tissues, the technology enhances decision support in diagnosing and monitoring the progression and therapeutic impact of brain diseases. Notably, the system's analysis of myelin volumes provides objective assessments for traumatic brain injuries, a groundbreaking feature replacing the reliance on symptom-based tests.

The collaboration between Philips and SyntheticMR combines Philips' AI-based SmartSmeed image-reconstruction technology and 3D syntAc with SyntheticMR’s SyMRI Neuro 3D quantitative tissue assessment software. This synergy results in a unique offering, making Philips the sole provider of SyMRI Neuro 3D capabilities on MR scanners. The joint solution employs AI to deliver fully verified, automatic 3D segmentation and volume measurement of brain tissue, encompassing white matter, grey matter, cerebrospinal fluid, and myelin. The significance of this advanced diagnostic tool lies in its ability to provide clinicians with precise quantitative data, facilitating the tracking of treatment impact, informed decision-making, and proactive management of neurological conditions.

Ruud Zwerink, Business Leader of MR at Philips, underscored the importance of Smart Quant Neuro 3D, stating that it equips clinicians with an easy-to-use tool for delivering valuable quantitative data. This empowers them to track treatment impacts, make informed decisions, and proactively manage neurological conditions, ultimately optimising therapeutic outcomes for patients.